Synvista Therapeutics, Inc. 4
4 · Synvista Therapeutics, Inc. · Filed Sep 17, 2007
Insider Transaction Report
Form 4
Berkowitz Noah
DirectorPresident & CEO10% Owner
Transactions
- Disposition to Issuer
Common Stock
2007-09-14$3.70/sh−65$241→ 118,025 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-14$3.38/sh−321$1,085→ 117,510 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-14$3.70/sh−161$596→ 117,864 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-17$3.11/sh−267$830→ 115,546 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-17$3.05/sh−542$1,653→ 114,878 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-14$3.40/sh−129$439→ 117,153 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-14$3.40/sh−481$1,635→ 116,542 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-17$3.22/sh−62$200→ 116,033 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-14$3.22/sh−160$515→ 116,156 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-14$3.75/sh−33$124→ 118,123 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-17$3.18/sh−122$388→ 115,911 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-17$3.28/sh−61$200→ 116,095 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-17$3.13/sh−36$113→ 115,813 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-09-17$3.11/sh−32$100→ 115,514 total(indirect: By Trust)
Footnotes (1)
- [F1]Transactions completed pursuant to a 10B5-1 plan.